Brief: Chinook Therapeutics Reports First Quarter 2022 Results
12/05/2022 21:01
May 12 (Reuters) - Chinook Therapeutics Inc KDNY.O :
* CHINOOK THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS
FIRST
QUARTER 2022 FINANCIAL RESULTS
* Q1 REVENUE $2.7 MILLION
* QTRLY NET LOSS PER SHARE ATTRIBUTABLE TO COMMON
STOCKHOLDERS,
BASIC AND DILUTED $0.54
Source text for Eikon: ID:nGNX6K9xcJ
Further company coverage: KDNY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chinook Therapeutics
See all newsBrief: Novartis Completes Acquisition Of Chinook Therapeutics
Chinook Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Chinook Therapeutics Inc expected to post a loss of 81 cents a share - Earnings Preview
Brief: Chinook Therapeutics Announces First Patient Enrolled In Phase 3 Of Zigakibart
Brief: Muddy Waters- Remains Short On Chinook Therapeutics Inc